Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
27.18
-0.39 (-1.41%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Tango Therapeutics Market Cap
Tango Therapeutics has a market cap or net worth of $3.93 billion as of July 31, 2026. Its market cap has increased by 475.73% in one year.
Market Cap
3.93B
Enterprise Value
3.58B
1-Year Change
475.73%
Ranking
Category
Stock Price
$27.18
ChartMarket Cap Chart
Since April 20, 2021, Tango Therapeutics's market cap has increased from $156.31M to $3.93B, an increase of 2,415.28%. That is a compound annual growth rate of 84.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 3.93B | 229.48% |
| Dec 31, 2025 | 1.19B | 259.49% |
| Dec 31, 2024 | 331.92M | -67.13% |
| Dec 29, 2023 | 1.01B | 57.94% |
| Dec 30, 2022 | 639.29M | -33.25% |
| Dec 31, 2021 | 957.76M | 512.74% |
| Apr 20, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.39B |
| Parabilis Medicines | 4.33B |
| Celcuity | 4.21B |
| Edgewise Therapeutics | 4.13B |
| Relay Therapeutics | 4.10B |
| Enliven Therapeutics | 3.83B |
| Viking Therapeutics | 3.70B |
| Denali Therapeutics | 3.65B |